Browse by Changes

Prescriber Bag

Additions

Addition – Item

15347R SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules (Salbutamol (as sulfate) (Accord, UK))

General Pharmaceutical Benefits

Additions

Addition – Item

15345P CALCIPOTRIOL + BETAMETHASONE DIPROPIONATE, calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel, 60 g (Actobet 50/500)
15352B CALCIPOTRIOL + BETAMETHASONE DIPROPIONATE, calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel, 60 g (Actobet 50/500)
15353C DAPAGLIFLOZIN, dapagliflozin 10 mg tablet, 28 (Forxiga)
15336E FRUQUINTINIB, fruquintinib 1 mg capsule, 21 (Fruzaqla)
15344N FRUQUINTINIB, fruquintinib 5 mg capsule, 21 (Fruzaqla)
15337F GLYCOPYRRONIUM, Glycopyrronium bromide 1% cream, 50 g (Axhidrox)
15339H LAMOTRIGINE, lamotrigine 5 mg tablet, 56 (Lamictal)
15341K LAMOTRIGINE, lamotrigine 5 mg tablet, 56 (Lamictal)
15338G LAMOTRIGINE, lamotrigine 25 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15346Q LAMOTRIGINE, lamotrigine 25 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15342L LAMOTRIGINE, lamotrigine 50 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15349W LAMOTRIGINE, lamotrigine 50 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15340J LAMOTRIGINE, lamotrigine 100 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15343M LAMOTRIGINE, lamotrigine 100 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15350X LAMOTRIGINE, lamotrigine 200 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15351Y LAMOTRIGINE, lamotrigine 200 mg tablet, 56 (Lamictal, Lamotrigine GH, Sandoz Lamotrigine)
15348T SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules (Salbutamol (as sulfate) (Accord, UK))

Addition – Brand

11941L COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
1891M COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
5008N COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 500 mg + clavulanic acid 125 mg tablet, 10
11933C COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 10
5006L COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 10
8254K COMOX, DZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 10
11963P Cefalexin Viatris, AL – CEFALEXIN, cefalexin 250 mg capsule, 20
2655R Cefalexin Viatris, AL – CEFALEXIN, cefalexin 250 mg capsule, 20
3058Y Cefalexin Viatris, AL – CEFALEXIN, cefalexin 250 mg capsule, 20
3317N Cefalexin Viatris, AL – CEFALEXIN, cefalexin 250 mg capsule, 20
3410L ARX-Colchicine, XT – COLCHICINE, colchicine 500 microgram tablet, 30
14349F ESCIT, DZ – ESCITALOPRAM, escitalopram 10 mg tablet, 28
14519E ESCIT, DZ – ESCITALOPRAM, escitalopram 10 mg tablet, 28
8700X ESCIT, DZ – ESCITALOPRAM, escitalopram 10 mg tablet, 28
9432K ESCIT, DZ – ESCITALOPRAM, escitalopram 10 mg tablet, 28
14415Q ESCIT, DZ – ESCITALOPRAM, escitalopram 20 mg tablet, 28
14416R ESCIT, DZ – ESCITALOPRAM, escitalopram 20 mg tablet, 28
8701Y ESCIT, DZ – ESCITALOPRAM, escitalopram 20 mg tablet, 28
9433L ESCIT, DZ – ESCITALOPRAM, escitalopram 20 mg tablet, 28
3440C ATTORA LA, XT – METHYLPHENIDATE, methylphenidate hydrochloride 10 mg modified release capsule, 30
2276T ATTORA LA, XT – METHYLPHENIDATE, methylphenidate hydrochloride 20 mg modified release capsule, 30
2280B ATTORA LA, XT – METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 30
2283E ATTORA LA, XT – METHYLPHENIDATE, methylphenidate hydrochloride 40 mg modified release capsule, 30
12116Q ATTORA LA, XT – METHYLPHENIDATE, methylphenidate hydrochloride 60 mg modified release capsule, 30
8839F Rinidate, NB – METHYLPHENIDATE, methylphenidate hydrochloride 10 mg tablet, 100
5295Q Palonosetron JN, XT – PALONOSETRON, palonosetron 250 microgram/5 mL injection, 5 mL vial
14006E TOBRAMYCIN WKT, XT – TOBRAMYCIN, tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules
5442K TOBRAMYCIN WKT, XT – TOBRAMYCIN, tobramycin 300 mg/5 mL inhalation solution, 56 x 5 mL ampoules
11180K ARX-URSODEOXYCHOLIC ACID, XT – URSODEOXYCHOLIC ACID, ursodeoxycholic acid 500 mg tablet, 100

Addition – Note

11095Y SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 20 x 2.5 mL ampoules (Ventolin Nebules)
2001H SALBUTAMOL, salbutamol 5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules (Salbutamol Cipla)

Deletions

Deletion – Item

10414D APIXABAN, apixaban 5 mg tablet, 28 (Eliquis)
12458Q DESMOPRESSIN, desmopressin acetate 10 microgram/actuation nasal spray, 50 actuations (Desmopressin Nasal Spray USP (Apotex))
12459R DESMOPRESSIN, desmopressin acetate 10 microgram/actuation nasal spray, 50 actuations (Desmopressin Nasal Spray USP (Apotex))
15026W METHYLPHENIDATE, methylphenidate hydrochloride 10 mg modified release capsule, 30 (Methylphenidate Orifarm 10 mg (Sweden))
15016H METHYLPHENIDATE, methylphenidate hydrochloride 20 mg modified release capsule, 30 (Methylphenidate Orifarm 20 mg (Sweden))
15046X METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 30 (Methylphenidate Orifarm 30 mg (Sweden))
15003P METHYLPHENIDATE, methylphenidate hydrochloride 60 mg modified release capsule, 30 (Methylphenidate Orifarm 60 mg (Denmark))
14854T NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada))

Deletion – Brand

8594H AMISULPRIDE-WGR, WG – AMISULPRIDE, amisulpride 100 mg tablet, 30
8318T NOUMED CLARITHROMYCIN, VO – CLARITHROMYCIN, clarithromycin 250 mg tablet, 14
13280Y Rythmodan (Canada), OJ – DISOPYRAMIDE, disopyramide 100 mg capsule, 84
13469X Fenofibrate Cipla, LR – FENOFIBRATE, fenofibrate 48 mg tablet, 60
9022W Fenofibrate Cipla, LR – FENOFIBRATE, fenofibrate 48 mg tablet, 60
10416F GLATIRAMER ACETATE-TEVA, EV – GLATIRAMER ACETATE, glatiramer acetate 40 mg/mL injection, 12 x 1 mL syringes
14473R NOUMED MIRTAZAPINE, VO – MIRTAZAPINE, mirtazapine 30 mg tablet, 30
8513C NOUMED MIRTAZAPINE, VO – MIRTAZAPINE, mirtazapine 30 mg tablet, 30
13898L Actos, GQ – PIOGLITAZONE, pioglitazone 15 mg tablet, 28
8694N Actos, GQ – PIOGLITAZONE, pioglitazone 15 mg tablet, 28
14057W Actos, GQ – PIOGLITAZONE, pioglitazone 45 mg tablet, 28
8696Q Actos, GQ – PIOGLITAZONE, pioglitazone 45 mg tablet, 28
14458Y RASAGILINE-WGR, WG – RASAGILINE, rasagiline 1 mg tablet, 30
1952R RASAGILINE-WGR, WG – RASAGILINE, rasagiline 1 mg tablet, 30
2285G NOUMED TERBINAFINE, VO – TERBINAFINE, terbinafine 250 mg tablet, 42
2804N NOUMED TERBINAFINE, VO – TERBINAFINE, terbinafine 250 mg tablet, 42
9009E Navelbine, FB – VINORELBINE, vinorelbine 20 mg capsule, 1
9010F Navelbine, FB – VINORELBINE, vinorelbine 30 mg capsule, 1

Deletion – Equivalence Indicator

1658G Phebra Naproxen Suspension, FF – NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL
9009E Velabine, XT – VINORELBINE, vinorelbine 20 mg capsule, 1
9010F Velabine, XT – VINORELBINE, vinorelbine 30 mg capsule, 1

Deletion – Note

1658G NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension)

Deletion – Restriction

14794P ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato)
14812N ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato)
14830M ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato)

Alterations

Alteration – Note

3440C METHYLPHENIDATE, methylphenidate hydrochloride 10 mg modified release capsule, 30 (ATTORA LA, Ritalin LA, Rubifen LA)
15109F METHYLPHENIDATE, methylphenidate hydrochloride 10 mg modified release capsule, 30 (Ritalin LA 10 mg (Switzerland))
2276T METHYLPHENIDATE, methylphenidate hydrochloride 20 mg modified release capsule, 30 (ATTORA LA, Ritalin LA, Rubifen LA)
15101T METHYLPHENIDATE, methylphenidate hydrochloride 20 mg modified release capsule, 30 (Ritalin LA 20 mg (Switzerland))
2280B METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 30 (ATTORA LA, Ritalin LA, Rubifen LA)
15099Q METHYLPHENIDATE, methylphenidate hydrochloride 30 mg modified release capsule, 30 (Ritalin LA 30 mg (Switzerland))
2283E METHYLPHENIDATE, methylphenidate hydrochloride 40 mg modified release capsule, 30 (ATTORA LA, Ritalin LA, Rubifen LA)
15100R METHYLPHENIDATE, methylphenidate hydrochloride 40 mg modified release capsule, 30 (Ritalin LA 40 mg (Switzerland))
12116Q METHYLPHENIDATE, methylphenidate hydrochloride 60 mg modified release capsule, 30 (ATTORA LA, Ritalin LA, Rubifen LA)

Alteration – Restriction

13525W APIXABAN, apixaban 5 mg tablet, 60 (Eliquis)
2735Y APIXABAN, apixaban 5 mg tablet, 60 (Eliquis)
11507P TRIFLURIDINE + TIPIRACIL, trifluridine 15 mg + tipiracil 6.14 mg tablet, 20 (Lonsurf 15/6.14)
12056M TRIFLURIDINE + TIPIRACIL, trifluridine 15 mg + tipiracil 6.14 mg tablet, 20 (Lonsurf 15/6.14)
11524M TRIFLURIDINE + TIPIRACIL, trifluridine 20 mg + tipiracil 8.19 mg tablet, 20 (Lonsurf 20/8.19)
12033H TRIFLURIDINE + TIPIRACIL, trifluridine 20 mg + tipiracil 8.19 mg tablet, 20 (Lonsurf 20/8.19)

Alteration – Manufacturer Code

From To
11123K SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 RM WG
13570F SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 RM WG
11131W SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 RM WG
13511D SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 RM WG
11122J SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 RM WG
13445P SACUBITRIL/VALSARTAN-WGR – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 RM WG

Supply Only

Supply Only - Period Commencing

14809K EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)

Supply Only - Period Ending

2863Q FLUVASTATIN, fluvastatin 80 mg modified release tablet, 28 (Lescol XL)
13558N FLUVASTATIN, fluvastatin 80 mg modified release tablet, 28 (Lescol XL)
10189G TRIGLYCERIDES LONG CHAIN WITH GLUCOSE POLYMER, triglycerides long chain with glucose polymer oral liquid, 27 x 200 mL cartons (Sno-Pro)

Advance Notices

1 June 2026

Deletion – Item

15069D Clopidogrel 75 mg (Zentiva, UK), LM – CLOPIDOGREL, clopidogrel 75 mg tablet, 28
15075K Clopidogrel 75 mg (Zentiva, UK), LM – CLOPIDOGREL, clopidogrel 75 mg tablet, 28
14853R Concerta (Switzerland), DZ – METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30
14858B Concerta (Switzerland), DZ – METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30
14861E Concerta (Switzerland), DZ – METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30
14874W Concerta (Switzerland), DZ – METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30
15169J Atenza (Spain), XT – METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30
15198X Atenza (Spain), XT – METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30
15024R Prazosin Hydrochloride Capsules, USP 2 mg (Novitium Pharma, USA), DZ – PRAZOSIN, prazosin 2 mg capsule, 100
15044T Prazosin Hydrochloride Capsules, USP 2 mg (Novitium Pharma, USA), DZ – PRAZOSIN, prazosin 2 mg capsule, 100

Delete - Brand

14408H Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
8612G Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets
13582W Tritace 1.25 mg, SW – RAMIPRIL, ramipril 1.25 mg tablet, 30
1944H Tritace 1.25 mg, SW – RAMIPRIL, ramipril 1.25 mg tablet, 30

1 July 2026

Deletion – Brand

14315K Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
5551E Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
8620Q Bimtop, AF – BIMATOPROST, bimatoprost 0.03% eye drops, 3 mL
8362D Capecitabine Sandoz, SZ – CAPECITABINE, capecitabine 500 mg tablet, 120
13385L EzSimva GH 10/10, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30
9483D EzSimva GH 10/10, GQ – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30
8887R Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 7.5 mg capsule, 30
8888T Meloxicam Sandoz, SZ – MELOXICAM, meloxicam 15 mg capsule, 30
13371R Idaprex 4, SZ – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
13372T Idaprex 8, SZ – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13404L Idaprex 2, SZ – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3050M Idaprex 2, SZ – PERINDOPRIL, perindopril erbumine 2 mg tablet, 30
3051N Idaprex 4, SZ – PERINDOPRIL, perindopril erbumine 4 mg tablet, 30
8704D Idaprex 8, SZ – PERINDOPRIL, perindopril erbumine 8 mg tablet, 30
13476G Idaprex Combi 4/1.25, SZ – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
8449Q Idaprex Combi 4/1.25, SZ – PERINDOPRIL + INDAPAMIDE, perindopril erbumine 4 mg + indapamide hemihydrate 1.25 mg tablet, 30
14458Y Rasagiline Sandoz, SZ – RASAGILINE, rasagiline 1 mg tablet, 30
1952R Rasagiline Sandoz, SZ – RASAGILINE, rasagiline 1 mg tablet, 30

1 August 2026

Deletion – Brand

3094W Keflex, AS – CEFALEXIN, cefalexin 125 mg/5 mL powder for oral liquid, 100 mL
3319Q Keflex, AS – CEFALEXIN, cefalexin 125 mg/5 mL powder for oral liquid, 100 mL
3382B OLANZAPINE ODT-WGR, WG – OLANZAPINE, olanzapine 10 mg orally disintegrating tablet, 28
8380C Temodal, MK – TEMOZOLOMIDE, temozolomide 100 mg capsule, 5
8821G Temodal, MK – TEMOZOLOMIDE, temozolomide 100 mg capsule, 5
9361Q Temodal, MK – TEMOZOLOMIDE, temozolomide 140 mg capsule, 5
9362R Temodal, MK – TEMOZOLOMIDE, temozolomide 140 mg capsule, 5

Palliative Care

Deletions

Deletion – Item

14867L NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada))

Deletion – Equivalence Indicator

5397C Phebra Naproxen Suspension, FF – NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL

Deletion – Note

5397C NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension)

Advance Notices

1 June 2026

Deletion – Brand

5389P Chemists' Own Macrogol with Electrolytes, RW – MACROGOL-3350 + SODIUM CHLORIDE + BICARBONATE + POTASSIUM CHLORIDE, macrogol-3350 13.125 g + sodium chloride 350.7 mg + sodium bicarbonate 178.5 mg + potassium chloride 46.6 mg powder for oral liquid, 30 sachets

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Note

11396T INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
11450P INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
11488P INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)

Deletions

Deletion – Brand

12146G Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
6430K Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
10566D Octreotide Depot, TB – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10549F Octreotide Depot, TB – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10558Q Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11894B Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Deletion – Equivalence Indicator

10566D Sandostatin LAR, NV – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10549F Sandostatin LAR, NV – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10558Q Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11894B Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Deletion – Restriction

14798W ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato)
14811M ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato)
14814Q ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato)
14829L VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)

Alterations

Alteration – Authorised Prescriber

From To
6320P DARBEPOETIN ALFA, darbepoetin alfa 10 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
6321Q DARBEPOETIN ALFA, darbepoetin alfa 20 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
6488L DARBEPOETIN ALFA, darbepoetin alfa 20 microgram/0.5 mL injection, 0.5 mL pen device (Aranesp SureClick) M M,N
6322R DARBEPOETIN ALFA, darbepoetin alfa 30 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
6323T DARBEPOETIN ALFA, darbepoetin alfa 40 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
6489M DARBEPOETIN ALFA, darbepoetin alfa 40 microgram/0.4 mL injection, 0.4 mL pen device (Aranesp SureClick) M M,N
6324W DARBEPOETIN ALFA, darbepoetin alfa 50 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
6325X DARBEPOETIN ALFA, darbepoetin alfa 60 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
6490N DARBEPOETIN ALFA, darbepoetin alfa 60 microgram/0.3 mL injection, 0.3 mL pen device (Aranesp SureClick) M M,N
6438W DARBEPOETIN ALFA, darbepoetin alfa 80 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
6491P DARBEPOETIN ALFA, darbepoetin alfa 80 microgram/0.4 mL injection, 0.4 mL pen device (Aranesp SureClick) M M,N
6326Y DARBEPOETIN ALFA, darbepoetin alfa 100 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
6492Q DARBEPOETIN ALFA, darbepoetin alfa 100 microgram/0.5 mL injection, 0.5 mL pen device (Aranesp SureClick) M M,N
6365B DARBEPOETIN ALFA, darbepoetin alfa 150 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
6493R DARBEPOETIN ALFA, darbepoetin alfa 150 microgram/0.3 mL injection, 0.3 mL pen device (Aranesp SureClick) M M,N
6251B EPOETIN ALFA, epoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 1000) M M,N
6204M EPOETIN ALFA, epoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 2000) M M,N
6205N EPOETIN ALFA, epoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (Eprex 3000) M M,N
6206P EPOETIN ALFA, epoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes (Eprex 4000) M M,N
6302Q EPOETIN ALFA, epoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 5000) M M,N
6303R EPOETIN ALFA, epoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes (Eprex 6000) M M,N
6305W EPOETIN ALFA, epoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes (Eprex 8000) M M,N
6207Q EPOETIN ALFA, epoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes (Eprex 10000) M M,N
6434P EPOETIN ALFA, epoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 20,000) M M,N
6339P EPOETIN ALFA, epoetin alfa 40 000 units/mL injection, 1 mL syringe (Eprex 40,000) M M,N
6480C EPOETIN BETA, epoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
6481D EPOETIN BETA, epoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
6482E EPOETIN BETA, epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
6483F EPOETIN BETA, epoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
6484G EPOETIN BETA, epoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
6485H EPOETIN BETA, epoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes (NeoRecormon) M M,N
9685R EPOETIN LAMBDA, epoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes (Novicrit) M M,N
9686T EPOETIN LAMBDA, epoetin lambda 2000 units/mL injection, 6 x 1 mL syringes (Novicrit) M M,N
9687W EPOETIN LAMBDA, epoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (Novicrit) M M,N
9688X EPOETIN LAMBDA, epoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes (Novicrit) M M,N
9588P EPOETIN LAMBDA, epoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes (Novicrit) M M,N
9590R EPOETIN LAMBDA, epoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes (Novicrit) M M,N
9593X EPOETIN LAMBDA, epoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes (Novicrit) M M,N
9595B EPOETIN LAMBDA, epoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes (Novicrit) M M,N
9574X METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 30 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9575Y METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9576B METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9577C METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 100 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9578D METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 120 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9579E METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
9580F METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 360 microgram/0.6 mL injection, 0.6 mL syringe (Mircera) M M,N

Advance Notices

1 July 2026

Deletion – Brand

12784W Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13033Y Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13038F Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13039G Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13040H Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
6100C Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
6138C Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Note

11400B INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
11449N INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)
11486M INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Ixifi, Remsima, Renflexis)

Deletions

Deletion – Brand

12149K Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
5619R Bosentan Mylan, AF – BOSENTAN, bosentan 125 mg tablet, 60
10543X Octreotide Depot, TB – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10533J Octreotide Depot, TB – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10550G Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11893Y Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Deletion – Equivalence Indicator

10543X Sandostatin LAR, NV – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10533J Sandostatin LAR, NV – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
10550G Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11893Y Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Deletion – Restriction

14821C ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 3 x 2 actuations (Spravato)
14822D ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 actuations (Spravato)
14837X ESKETAMINE, esketamine 28 mg/2 actuations nasal spray, 2 x 2 actuations (Spravato)
14810L VUTRISIRAN, Vutrisiran 25 mg/0.5 mL injection, 0.5 mL syringe (Amvuttra)

Alterations

Alteration – Authorised Prescriber

From To
5637Q DARBEPOETIN ALFA, darbepoetin alfa 10 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
5638R DARBEPOETIN ALFA, darbepoetin alfa 20 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
5645D DARBEPOETIN ALFA, darbepoetin alfa 20 microgram/0.5 mL injection, 0.5 mL pen device (Aranesp SureClick) M M,N
5639T DARBEPOETIN ALFA, darbepoetin alfa 30 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
5640W DARBEPOETIN ALFA, darbepoetin alfa 40 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
5646E DARBEPOETIN ALFA, darbepoetin alfa 40 microgram/0.4 mL injection, 0.4 mL pen device (Aranesp SureClick) M M,N
5641X DARBEPOETIN ALFA, darbepoetin alfa 50 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
5642Y DARBEPOETIN ALFA, darbepoetin alfa 60 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
5647F DARBEPOETIN ALFA, darbepoetin alfa 60 microgram/0.3 mL injection, 0.3 mL pen device (Aranesp SureClick) M M,N
5644C DARBEPOETIN ALFA, darbepoetin alfa 80 microgram/0.4 mL injection, 4 x 0.4 mL syringes (Aranesp) M M,N
5648G DARBEPOETIN ALFA, darbepoetin alfa 80 microgram/0.4 mL injection, 0.4 mL pen device (Aranesp SureClick) M M,N
5649H DARBEPOETIN ALFA, darbepoetin alfa 100 microgram/0.5 mL injection, 0.5 mL pen device (Aranesp SureClick) M M,N
5651K DARBEPOETIN ALFA, darbepoetin alfa 100 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Aranesp) M M,N
5643B DARBEPOETIN ALFA, darbepoetin alfa 150 microgram/0.3 mL injection, 4 x 0.3 mL syringes (Aranesp) M M,N
5650J DARBEPOETIN ALFA, darbepoetin alfa 150 microgram/0.3 mL injection, 0.3 mL pen device (Aranesp SureClick) M M,N
5714R EPOETIN ALFA, epoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 1000) M M,N
5719B EPOETIN ALFA, epoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 2000) M M,N
5720C EPOETIN ALFA, epoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (Eprex 3000) M M,N
5721D EPOETIN ALFA, epoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes (Eprex 4000) M M,N
5715T EPOETIN ALFA, epoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 5000) M M,N
5716W EPOETIN ALFA, epoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes (Eprex 6000) M M,N
5717X EPOETIN ALFA, epoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes (Eprex 8000) M M,N
5722E EPOETIN ALFA, epoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes (Eprex 10000) M M,N
5713Q EPOETIN ALFA, epoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes (Eprex 20,000) M M,N
5718Y EPOETIN ALFA, epoetin alfa 40 000 units/mL injection, 1 mL syringe (Eprex 40,000) M M,N
5724G EPOETIN BETA, epoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
5725H EPOETIN BETA, epoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
5726J EPOETIN BETA, epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
5727K EPOETIN BETA, epoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
5728L EPOETIN BETA, epoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes (NeoRecormon) M M,N
5729M EPOETIN BETA, epoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes (NeoRecormon) M M,N
9668W EPOETIN LAMBDA, epoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes (Novicrit) M M,N
9669X EPOETIN LAMBDA, epoetin lambda 2000 units/mL injection, 6 x 1 mL syringes (Novicrit) M M,N
9670Y EPOETIN LAMBDA, epoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes (Novicrit) M M,N
9587N EPOETIN LAMBDA, epoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes (Novicrit) M M,N
9589Q EPOETIN LAMBDA, epoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes (Novicrit) M M,N
9591T EPOETIN LAMBDA, epoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes (Novicrit) M M,N
9594Y EPOETIN LAMBDA, epoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes (Novicrit) M M,N
9596C EPOETIN LAMBDA, epoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes (Novicrit) M M,N
5794Y METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 30 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5795B METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 50 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5796C METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5797D METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 100 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5798E METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 120 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5799F METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 200 microgram/0.3 mL injection, 0.3 mL syringe (Mircera) M M,N
5800G METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, methoxy polyethylene glycol-epoetin beta 360 microgram/0.6 mL injection, 0.6 mL syringe (Mircera) M M,N

Advance Notices

1 July 2026

Deletion – Brand

12771E Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13028Q Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13036D Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13042K Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
13044M Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
9597D Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial
9598E Azacitidine Sandoz, SZ – AZACITIDINE, azacitidine 100 mg injection, 1 vial

Highly Specialised Drugs Program (Community Access)

Deletions

Deletion – Brand

11501H Octreotide Depot, TB – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11537F Octreotide Depot, TB – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11512X Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11896D Octreotide Depot, TB – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Deletion – Equivalence Indicator

11501H Sandostatin LAR, NV – OCTREOTIDE, octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11537F Sandostatin LAR, NV – OCTREOTIDE, octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11512X Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
11896D Sandostatin LAR, NV – OCTREOTIDE, octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack

Botulinum Toxin Program

Alterations

Alteration – Restriction

11016T BOTULINUM TOXIN TYPE A, botulinum toxin type A 100 units injection, 1 vial (Botox)

Repatriation Pharmaceutical Benefits

Deletions

Deletion – Brand

10177P Colaxsen, AS – DOCUSATE + SENNOSIDE B, docusate sodium 50 mg + sennoside B 8 mg tablet, 90
 

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Brand

7246J GEMCITABINE EUGIA, YG – GEMCITABINE, gemcitabine 1 g/25 mL injection, 25 mL vial
7246J GEMCITABINE EUGIA, YG – GEMCITABINE, gemcitabine 2 g/50 mL injection, 50 mL vial

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Brand

4439P GEMCITABINE EUGIA, YG – GEMCITABINE, gemcitabine 1 g/25 mL injection, 25 mL vial
4439P GEMCITABINE EUGIA, YG – GEMCITABINE, gemcitabine 2 g/50 mL injection, 50 mL vial

Related Pharmaceutical Benefits for Public Hospital use

Additions

Addition – Brand

5853C Palonosetron JN, XT – PALONOSETRON, palonosetron 250 microgram/5 mL injection, 5 mL vial

Supply Only

Supply Only - Period Commencing

14826H EPCORITAMAB, Epcoritamab 48 mg/0.8 mL injection, 0.8 mL vial (Epkinly)